<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ribavirin/PMC3854647/results/search/disease/results.xml">
  <result pre=": Research Article Prescription of antiviral drugs during the 2009" exact="influenza" post="pandemic: an observational study using electronic medical files of"/>
  <result pre="accordance with the recommendations, what proportion of patients diagnosed with" exact="influenza" post="had been prescribed antiviral drugs, and to what extent"/>
  <result pre="had been prescribed antiviral medication (n = 351) or were diagnosed with" exact="influenza" post="(n = 3293). Results Of all antiviral prescriptions, 69% were in"/>
  <result pre="accordance with the recommendations. Only 5% of patients diagnosed with" exact="influenza" post="were prescribed antiviral drugs. This percentage increased to 12%"/>
  <result pre="were prescribed antiviral drugs. This percentage increased to 12% among" exact="influenza" post="patients belonging to the designated high risk groups. On"/>
  <result pre="designated high risk groups. On the other hand, 2.5% of" exact="influenza" post="patients not at high risk of complications received antiviral"/>
  <result pre="Netherlands have been restrictive in prescribing antiviral drugs during the" exact="influenza" post="pandemic, even when patients met the criteria for antiviral"/>
  <result pre="topic Background On April 30th 2009, the first case of" exact="influenza" post="A(H1N1)pdm09 was identified in the Netherlands, while it eventually"/>
  <result pre="in the Netherlands, while it eventually caused an epidemic with" exact="influenza" post="activity above baseline in the period 12 October through"/>
  <result pre="hemisphere) [1]. During the emerging pandemic, all patients suspected of" exact="influenza" post="were indicated for treatment with antiviral drugs and their"/>
  <result pre="on morbidity and mortality appeared to be similar to seasonal" exact="influenza" post="virus, based on its so far documented relatively mild"/>
  <result pre="for severe disease and patients having a complicated course of" exact="influenza" post="[5]. Prophylactic prescriptions were no longer recommended. High risk"/>
  <result pre="patients were defined as the same patients eligible for seasonal" exact="influenza" post="vaccination, i.e. all patients of 60 years or above"/>
  <result pre="women in their third trimester, and patients having symptoms of" exact="influenza" post="in whom the infection occurred to be unusually severe"/>
  <result pre="first choice for treatment of high risk patients suspected of" exact="influenza" post="during the pandemic. Treatment with zanamivir was reserved for"/>
  <result pre="reserved for patients suspected for an infection with a resistant" exact="influenza" post="virus. Oseltamivir was only available as a prescription drug,"/>
  <result pre="practices’ characteristics, and 2) what proportion of patients diagnosed with" exact="influenza" post="received oseltamivir and which factors determined this prescription. Methods"/>
  <result pre="registered at the same day. We specifically considered diagnoses of" exact="influenza" post="(ICPC-code R80, which will be used by GPs for"/>
  <result pre="for patients with influenza-like illness in the context of an" exact="influenza" post="epidemic, or upon virological confirmation of an influenza virus),"/>
  <result pre="of an influenza epidemic, or upon virological confirmation of an" exact="influenza" post="virus), another acute respiratory infection (ARI, defined by ICPC-codes"/>
  <result pre="used by GPs for patients with influenza-like illness outside the" exact="influenza" post="season). Patients who did not receive oseltamivir were evaluated"/>
  <result pre="on age (&amp;lt;2 years or ≥60 years), co-morbidity (cardiac disease," exact="respiratory disease," post="diabetes mellitus, chronic renal insufficiency, reduced resistance against infections"/>
  <result pre="(&amp;lt;2 years or ≥60 years), co-morbidity (cardiac disease, respiratory disease," exact="diabetes mellitus," post="chronic renal insufficiency, reduced resistance against infections and children"/>
  <result pre="using salicylates), a complicated course of illness (the occurrence of" exact="pneumonia" post="within 7 days before or after the diagnosis of"/>
  <result pre="pneumonia within 7 days before or after the diagnosis of" exact="influenza" post="or ARI, or the need to prescribe antibiotics –"/>
  <result pre="or a third trimester pregnancy (an oseltamivir prescription or an" exact="influenza" post="diagnosis between 20 to 34 weeks after a first"/>
  <result pre="be no more than 14 weeks after oseltamivir prescription or" exact="influenza" post="diagnosis). Details on ICPC- and ATC-codes used to classify"/>
  <result pre="Half of the patients receiving oseltamivir had a diagnosis of" exact="influenza" post="(n = 181; 51.6%). The most frequently registered diagnoses in 105"/>
  <result pre="infection were general disease (21 patients), fever (17 patients), other" exact="viral disease" post="(12 patients), and ‘no disease’ (11 patients). No valid"/>
  <result pre="3,293 patients (1.3% of the study population) were diagnosed with" exact="influenza" post="and oseltamivir was prescribed to 181 (5.5%). The weekly"/>
  <result pre="oseltamivir was prescribed to 181 (5.5%). The weekly number of" exact="influenza" post="patients followed well the epidemiologic curve of the Dutch"/>
  <result pre="influenza-like illness (IAZ) surveillance (data not shown) [1]. Of all" exact="influenza" post="patients, 1,051 (31.9%) belonged to the designated high risk"/>
  <result pre="of age. On the other hand, 2,242 patients diagnosed with" exact="influenza" post="did not belong to the high risk groups and"/>
  <result pre="in 2009 were determinants of the prescription of oseltamivir among" exact="influenza" post="patients (Table 3). Patients with underlying co-morbidity had the"/>
  <result pre="were observed for other underlying diseases. Ten percent of all" exact="influenza" post="patients had a complicated course of illness, but this"/>
  <result pre="influencing the prescription of oseltamivir by general practitioners to 3,293" exact="influenza" post="patients Prescription of oseltamivir, n of patients (%) Univariate"/>
  <result pre="prescriptions was positively associated with the prescription of oseltamivir. Among" exact="influenza" post="patients who did not belong to the designated high"/>
  <result pre="4 Potential factors influencing the prescription of oseltamivir to 2,242" exact="influenza" post="patients not at high risk Prescription of oseltamivir, n"/>
  <result pre="the Netherlands have been restrained in prescribing oseltamivir during the" exact="influenza" post="pandemic. Only 5% of all patients diagnosed with influenza"/>
  <result pre="the influenza pandemic. Only 5% of all patients diagnosed with" exact="influenza" post="were prescribed oseltamivir, and only 12% of those who"/>
  <result pre="followed the recommendations in the national guidelines. Only 2.5% of" exact="influenza" post="patients not at high risk were prescribed oseltamivir, and"/>
  <result pre="are used in general practices to select patients eligible for" exact="influenza" post="vaccination [10,11]. This method has been used to monitor"/>
  <result pre="[10,11]. This method has been used to monitor the Dutch" exact="influenza" post="vaccination rate in different high risk groups for several"/>
  <result pre="by Hersh and colleagues, antivirals were prescribed in 58% of" exact="influenza" post="visits to US ambulatory physicians [15]. The prescription rate"/>
  <result pre="have been very restrained in prescribing antiviral drugs during the" exact="influenza" post="pandemic. Where GPs have used antiviral medication, they have"/>
  <result pre="den WijngaardCCHaagsmaJADonkerGAMeijerAvan der HoekWLugnérAKKretzschmarMEvan der SandeMAThe burden of 2009 pandemic" exact="influenza" post="A(H1N1) in the NetherlandsEur J Public Health20122215015710.1093/eurpub/ckq18721183472 van ‘t"/>
  <result pre="WijngaardCCvan der SandeMAvan der HoekWSurveillance of hospitalisations for 2009 pandemic" exact="influenza" post="A(H1N1) in the Netherlands, 5 June – 31 December"/>
  <result pre="Norwegian Institute of Public Health TackenMMulderJVisscherSTiersmaWDonkersJVerheijRBraspenningJMonitoring vaccination rate Dutch national" exact="influenza" post="prevention program 2009 [in Dutch]2010LINH: Nijmegen/Utrecht Van EssenGABuevingHJVoordouwACGBergHFVan der"/>
  <result pre="Van EssenGABuevingHJVoordouwACGBergHFVan der LaanJRde Jeude CPVLBoomsmaLJOpsteltenWDutch College of General Practitioners-guideline" exact="influenza" post="and influenza vaccination (first revision) [in Dutch]Huisarts Wet200851appendix 1–2"/>
  <result pre="der LaanJRde Jeude CPVLBoomsmaLJOpsteltenWDutch College of General Practitioners-guideline influenza and" exact="influenza" post="vaccination (first revision) [in Dutch]Huisarts Wet200851appendix 1–2 TackenMAJBBraspenningJCCBerendeAHakEDe BakkerDHGroenewegenPPGrolRPVaccination"/>
  <result pre="TackenMBraspenningJSpreeuwenbergPVan den HoogenHVan EssenGDe BakkerDGrolRPatient characteristics determine differences in the" exact="influenza" post="vaccination rate more so than practice featuresPrev Med20023540140610.1006/pmed.2002.108312453719 FietjéEHPhilbertDvan"/>
  <result pre="than practice featuresPrev Med20023540140610.1006/pmed.2002.108312453719 FietjéEHPhilbertDvan GeffenECWintersNABouvyMLAdherence to oseltamivir guidelines during" exact="influenza" post="pandemic, the NetherlandsEmerg Infect Dis20121853453510.3201/eid1803.11135122377063 HershALStaffordRSAntiviral prescribing by office-based"/>
  <result pre="Assess20101410918220630123 AzizMVasooSAzizZPatelSEltoukhyNSinghKOseltamivir overuse at a Chicago hospital during the 2009" exact="influenza" post="pandemic and the poor predictive value of influenza-like illness"/>
 </snippets>
</snippetsTree>
